课题基金 / 基金详情

Point of Care Center for Emerging Neurotechnologies (POC-CENT)

Point of Care Center for Emerging Neurotechnologies (POC-CENT)
新兴神经技术护理点中心 (POC-CENT)
批准号:
7342166
负责人:
Fred Richard Beyette
金额:
$187.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2012-06-30

项目摘要

项目成果

Fred Richard Beyette的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Point-of-Care Center for Emerging Neuro Technologies (POC-CENT) is focused on developing diagnostic technologies for neurologic emergencies where information is needed by the physician quickly. The remit for the technologies to be developed is to advance point-of-care information and information flow for the neurologic patient in the emergency room, neurosurgery suite, for neuroradiology and the neurosurgical intensive care unit. Indeed anytime the physician requires rapid information from the neurologic patient it will be considered as having potential need for point-of-care diagnostic information. This will include but not be limited to: blood tests, urinalysis, imaging, non-invasive sensors, spinal fluid, and biopsy / tissue samples. In the POC-CENT, there are 5 cores representing numerous disciplines to foster and facilitate taking ideas and applying them to clinical applications. These cores are: 1) Clinical testing, 2) Exploratory projects 3) Clinical Needs Assessment, 4) Training and 5) Administration. Supporting these cores we have representatives from Neurology, Neurosurgery, Engineering, Entrepreneurial Development, The Business Community, The Medical Device Industry and University Administration. A strength of the University of Cincinnati and the Cincinnati community is that we currently do all of these cores for our life sciences community. We have multiple incubators for companies, strong clinical trials experience, a wealth of training and funding opportunities for all stages of technology development. Indeed there will be an opportunity to partner with other funding agencies locally to add value to the technologies that enter into our program. Our team's goal is to improve the care and health of the neurologic patients by providing fast and reliable information about the biolocal event they are experiencing. We will achieve this goal by developing a pipeline of technologies and a pathway to develop emerging neuro technologies focused on point-of-care diagnostics. Further, we will work closely in the region and with the POCT Research Network to accomplish our goals. We are fortunate to have an engineering, medical, scientific and commercial community that already works well together and can be facilitated to do all the aspects of this project as part of the POCT Research Network.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Testing of Clinical Devices
  • 批准号:
    8153446
  • 项目类别:
  • 资助金额:
    $69.08万
  • 财政年份:
    2010
  • 负责人:
    Fred Richard Beyette
  • 依托单位:
Training
  • 批准号:
    8153455
  • 项目类别:
  • 资助金额:
    $36.08万
  • 财政年份:
    2010
  • 负责人:
    Fred Richard Beyette
  • 依托单位:
Clinical Needs Assessment
  • 批准号:
    8153453
  • 项目类别:
  • 资助金额:
    $30.65万
  • 财政年份:
    2010
  • 负责人:
    Fred Richard Beyette
  • 依托单位:
Plan for Identifying Collaborative Projects
  • 批准号:
    8153451
  • 项目类别:
  • 资助金额:
    $24.88万
  • 财政年份:
    2010
  • 负责人:
    Fred Richard Beyette
  • 依托单位:
国内基金
海外基金
基于CARE解码框架的跨范式肌电无声语音识别新方法
  • 批准号:
    2026JJ70025
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谭欣
  • 依托单位:
CarE06介导朱砂叶螨对甲氰菊酯对映体代谢抗性形成差异机制
  • 批准号:
    CSTB2023NSCQ-MSX0916
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2023
  • 负责人:
    张平
  • 依托单位:
棉铃虫羧酸酯酶CarE001G在杀虫剂代谢和抗性中的作用及机制
  • 批准号:
    U1903111
  • 项目类别:
    联合基金项目
  • 资助金额:
    57万元
  • 批准年份:
    2019
  • 负责人:
    李永强
  • 依托单位:
棉铃虫羧酸酯酶CarE001C定向进化及突变酶的结构与功能研究
  • 批准号:
    31201517
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2012
  • 负责人:
    李永强
  • 依托单位: